Pituitary and Neuroendocrine Disorders Resource Center

Increase your value as a vital team member with these specialized resources.

We strive to be the leading resource for clinicians at all levels of care. Thus, our Pituitary and Neuroendocrine Disorders Resource Center offers end-to-end expertise and clinical educational tools to ensure that you and other health-care team members are in sync in selecting the best course of clinical action for these complex and highly variable disease presentations.

If you're interested in pituitary and neuroendocrine disorders, you may enjoy episodes 1 and 4 of the new AACE Podcasts.

CLINICAL QUIZ: Pituitary and Neuroendocrine Case Questions

Neuroendocrine Case 3

26 years healthy transgender male without any medical history came to see you for cross-sex hormone therapy.

Neuroendocrine Case 2

A 45-year-old man who underwent transsphenoidal resection of a clinically non-functioning pituitary macroadenoma 6 months ago returns for endocrine follow-up. He says that his stamina and overall well-being have diminished since he underwent pituitary surgery. He has gained 10 lb postoperatively. He reports no headache, visual symptoms, nausea, constipation, dizziness, polyuria, low libido, erectile dysfunction, edema. His past medical history is otherwise significant for gastro-esophageal reflux disease but no diabetes mellitus or malignancy.

Neuroendocrine Case 1

James is 5 years old and has had worsening headaches for several weeks. He awakens with repeated vomiting. His parents rush him to the emergency room where he has a generalized seizure. A computerized tomography (CT) scan shows a posterior fossa tumor and hydrocephalus. He is admitted to the hospital and an emergency ventriculoperitoneal shunt is placed. Magnetic resonance imaging (MRI) confirms a likely medulloblastoma. In discussion with oncology, parents ask about future effects of treatment for the tumor.

View all Pituitary and Neuroendocrine Clinical Cases

CLINICAL PRACTICE GUIDELINES

AACE/ACE Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care – 2019 Update

This updated guideline provides evidence-based recommendations regarding the identification, screening, assessment, diagnosis, and treatment for a range of individuals with various causes of adult growth-hormone deficiency (GHD) and patients with childhood-onset GHD transitioning to adult care.

American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care - 2019 Update

The incidence of adrenal incidentaloma, a term coined in reference to the phenomenon of detecting an otherwise unsuspected adrenal mass on radiologic imaging, has been increasing and now approaches the 8.7% incidence reported in autopsy series.

View all Guidelines

SLIDE LIBRARY

Diagnosing and Treating Patients for AGHD

How do you know when to test for AGHD? This slide library will help you determine the answer and provide detailed information on testing and treatment of AGHD.

Download Slides (PDF)

View all Slide Library

SCIENTIFIC ARTICLES

AACE Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem

Off-label use and misuse of testosterone, GH, thyroid hormone, and adrenal supplements have become increasingly prevalent.

Endocrine Practice - the Journal for Clinical Endocrinology

Endocrine Practice, our official journal, keeps you on the leading edge of endocrine patient care.

AACE Clinical Case Reports

Access a wide range of case reports, visual vignettes and commentary from noted endocrinology experts.

View all Articles

American Association of Clinical Endocrinology Disease State Clinical Review - Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based

AACE Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem

Off-label use and misuse of testosterone, GH, thyroid hormone, and adrenal supplements have become increasingly prevalent.

Since its inception, the American Association of Clinical Endocrinologists (AACE) has advocated for the finest in endocrine education and state-of-the-art health-care delivery without regard to race, ethnicity, gender, age, country of origin, economic status, lifestyle, sexual orientation or domestic living arrangements.

View all Position Statements

AACE 2023 Annual Meeting | May 4 - 6 | Seattle, WA Learn More

Pituitary and Neuroendocrine Resource Center